These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7090928

  • 1. Monocyte activation by immune complexes of patients with SLE.
    Kávai M, Zsindely A, Sonkoly I, Bányai A, Szegedi G.
    Adv Exp Med Biol; 1982; 141():575-82. PubMed ID: 7090928
    [Abstract] [Full Text] [Related]

  • 2. Signals of monocyte activation in patients with SLE.
    Kávai M, Zsindely A, Sonkoly I, Major M, Demján I, Szegedi G.
    Clin Exp Immunol; 1983 Feb; 51(2):255-60. PubMed ID: 6839541
    [Abstract] [Full Text] [Related]

  • 3. Defective immune complex degradation by monocytes in patients with systemic lupus erythematosus.
    Kávai M, Csipö I, Sonkoly I, Csongor J, Szegedi GY.
    Scand J Immunol; 1986 Nov; 24(5):527-32. PubMed ID: 3787186
    [Abstract] [Full Text] [Related]

  • 4. Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor-ligand binding and internalization.
    Salmon JE, Kimberly RP, Gibofsky A, Fotino M.
    J Immunol; 1984 Nov; 133(5):2525-31. PubMed ID: 6481162
    [Abstract] [Full Text] [Related]

  • 5. Enhanced Fc receptor function of monocytes from patients with clinically active systemic lupus erythematosus: binding and degradation of soluble immune complexes in vitro.
    Kabashima T, Sakurai T, Yamane K, Kono I, Kashiwagi H.
    Jpn J Med; 1986 Aug; 25(3):263-9. PubMed ID: 3773319
    [Abstract] [Full Text] [Related]

  • 6. Loss of monocyte membrane receptors in patients with SLE.
    Kávai M, Lukács K, Sonkoly I, Jókay IJ, Berndt A, Szegedi G.
    Clin Exp Immunol; 1980 Apr; 40(1):66-71. PubMed ID: 7389218
    [Abstract] [Full Text] [Related]

  • 7. Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE).
    Hurst NP, Nuki G, Wallington T.
    Clin Exp Immunol; 1984 Feb; 55(2):303-12. PubMed ID: 6697566
    [Abstract] [Full Text] [Related]

  • 8. Effects of immune complexes from SLE patients on human monocyte locomotion and Fc receptor function.
    Lukács K, Kávai M, Bányai A, Sonkoly I, Végh E, Szabó G, Szegedi G.
    Ann Rheum Dis; 1984 Oct; 43(5):729-33. PubMed ID: 6333850
    [Abstract] [Full Text] [Related]

  • 9. Immune complex clearance by monocytes and macrophages in systemic lupus erythematosus.
    Kavai M, Szegedi G.
    Autoimmun Rev; 2007 Aug; 6(7):497-502. PubMed ID: 17643939
    [Abstract] [Full Text] [Related]

  • 10. Monocyte lysosomal enzyme release in response to naturally occurring circulating immune complexes.
    Aggarwal R, Batten S, Cockerell R, Tanner AR.
    Scand J Immunol; 1984 Feb; 19(2):159-64. PubMed ID: 6701473
    [Abstract] [Full Text] [Related]

  • 11. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL, Mason JC, Davies KA.
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Altered phagocytosis by monocytes from HLA-DR2 and DR3-positive healthy adults is Fc gamma receptor specific.
    Salmon JE, Kimberly RP, Gibofsky A, Fotino M.
    J Immunol; 1986 May 15; 136(10):3625-30. PubMed ID: 3009607
    [Abstract] [Full Text] [Related]

  • 14. Monocyte in vitro function in systemic lupus erythematosus (SLE). I. A clinical and immunological study.
    Svensson B.
    Scand J Rheumatol Suppl; 1980 May 15; 31():29-41. PubMed ID: 6992266
    [Abstract] [Full Text] [Related]

  • 15. Effect of soluble immune complexes of Fc and C3 receptor-dependent phagocytosis by human monocytes.
    Kávai M, Sándor M, Szegedi G, Füst G, Gergely J.
    Immunology; 1981 Nov 15; 44(3):599-606. PubMed ID: 7033117
    [Abstract] [Full Text] [Related]

  • 16. The effect of sera from patients with connective tissue diseases on red cell binding and phagocytosis by monocytes.
    Temple A, Loewi G.
    Immunology; 1977 Jul 15; 33(1):109-14. PubMed ID: 873570
    [Abstract] [Full Text] [Related]

  • 17. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus.
    Burbano C, Villar-Vesga J, Orejuela J, Muñoz C, Vanegas A, Vásquez G, Rojas M, Castaño D.
    Front Immunol; 2018 Jul 15; 9():322. PubMed ID: 29545790
    [Abstract] [Full Text] [Related]

  • 18. Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus.
    Meryhew NL, Kimberly RP, Messner RP, Runquist OA.
    J Immunol; 1986 Jul 01; 137(1):97-102. PubMed ID: 3486919
    [Abstract] [Full Text] [Related]

  • 19. Saturable, high-avidity monocyte receptors for monomeric IgG and Fc fragments increase in SLE and lyme disease.
    Hardin JA, Downs JT.
    Clin Exp Rheumatol; 1983 Jul 01; 1(4):327-32. PubMed ID: 6241857
    [Abstract] [Full Text] [Related]

  • 20. Decreased Fc receptor avidity and degradative function of monocytes from patients with systemic lupus erythematosus.
    Katayama S, Chia D, Knutson DW, Barnett EV.
    J Immunol; 1983 Jul 01; 131(1):217-22. PubMed ID: 6223072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.